Etid klinik pou Atak kè nan Virginia
4 etid pou Atak kè ap chèche patisipan nan sit nan Virginia.
Vil nan Virginia
Tèks ofisyèl etid la (Anglè)
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
- DCR-Norfolk Great Bridge, Chesapeake
- Nephrology Associates of Northern Virginia Inc, Fairfax
- Peninsula Kidney Associates, Hampton
- ak 2 plis
Ap rekriteFaz 2/3
Laj 18 ak plis · Tout sèks · Mizajou Sep 21, 2026 · NCT05485961An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)
- Inova Fairfax Hospital, Falls Church
- Virginia Heart, Falls Church
- Carient Heart and Vascular, Manassas
- ak 1 plis
Ap rekriteFaz 3
Laj 18 a 100 · Tout sèks · Mizajou Sep 4, 2026 · NCT07517263OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
- Inova Cardiology - Fairfax, Fairfax
- Virginia Heart, Falls Church
- Virginia Heart - Loudoun, Leesburg
- ak 6 plis
Ap rekriteFaz 3
Laj 50 a 105 · Tout sèks · Mizajou Aug 21, 2026 · NCT07136012Low Dose ColchicinE in pAtients With Peripheral Artery DiseasE to Address Residual Vascular Risk
- Sentara Norfolk General Hospital, Norfolk
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Mar 24, 2026 · NCT04774159Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.